TELA Bio, Inc(NASDAQ:TELA) 
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdomina...
Website: http://www.telabio.com
Founded: 2012
IPO Price: $13 (Nov 08, 2019)
Full Time Employees: 89
CEO: Antony Koblish
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 19,059,000 | 20,869,000 | 20,689,000 | 20,197,000 | 18,520,000 | 17,649,000 | 18,957,000 | 16,091,000 | 16,603,000 | 16,998,000 | 15,052,000 | 14,494,000 | 11,909,000 | 11,622,000 | 11,159,000 | 10,406,000 | 8,231,000 | 8,374,000 | 7,654,000 | 7,558,000 | 5,877,000 | 5,667,000 | 5,313,000 | 3,507,000 | 3,726,000 | 4,864,000 | 3,973,000 |
yoy | 2.91% | 18.24% | 9.14% | 25.52% | 11.55% | 3.83% | 25.94% | 11.02% | 39.42% | 46.26% | 34.89% | 39.29% | 44.68% | 38.79% | 45.79% | 37.68% | 40.05% | 47.77% | 44.06% | 115.51% | 57.73% | 16.51% | 33.73% | ||||
qoq | -8.67% | 0.87% | 2.44% | 9.06% | 4.94% | -6.90% | 17.81% | -3.08% | -2.32% | 12.93% | 3.85% | 21.71% | 2.47% | 4.15% | 7.24% | 26.42% | -1.71% | 9.41% | 1.27% | 28.60% | 3.71% | 6.66% | 51.50% | -5.88% | -23.40% | 22.43% | |
cost of revenue | 6,444,000 | 7,019,000 | 6,625,000 | 5,997,000 | 5,913,000 | 6,333,000 | 6,004,000 | 4,923,000 | 5,172,000 | 5,279,000 | 4,568,000 | 4,198,000 | 3,916,000 | 3,351,000 | 3,745,000 | 3,318,000 | 3,156,000 | 2,639,000 | 2,976,000 | 2,395,000 | 2,336,000 | 1,929,000 | 1,950,000 | 1,346,000 | 1,450,000 | 1,825,000 | 1,293,000 |
amortization of intangible assets | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 538,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 |
gross profit | 12,520,000 | 13,755,000 | 13,969,000 | 14,105,000 | 12,512,000 | 11,221,000 | 12,858,000 | 11,073,000 | 11,336,000 | 11,624,000 | 10,389,000 | 10,201,000 | 7,898,000 | 8,176,000 | 7,319,000 | 6,550,000 | 4,999,000 | 5,659,000 | 4,602,000 | 5,087,000 | 3,465,000 | 3,662,000 | 3,287,000 | 2,085,000 | 2,200,000 | 2,963,000 | 2,604,000 |
yoy | 0.06% | 22.58% | 8.64% | 27.38% | 10.37% | -3.47% | 23.77% | 8.55% | 43.53% | 42.17% | 41.95% | 55.74% | 57.99% | 44.48% | 59.04% | 28.76% | 44.27% | 54.53% | 40.01% | 143.98% | 57.50% | 23.59% | 26.23% | ||||
qoq | -8.98% | -1.53% | -0.96% | 12.73% | 11.51% | -12.73% | 16.12% | -2.32% | -2.48% | 11.89% | 1.84% | 29.16% | -3.40% | 11.71% | 11.74% | 31.03% | -11.66% | 22.97% | -9.53% | 46.81% | -5.38% | 11.41% | 57.65% | -5.23% | -25.75% | 13.79% | |
gross margin % | 65.69% | 65.91% | 67.52% | 69.84% | 67.56% | 63.58% | 67.83% | 68.81% | 68.28% | 68.38% | 69.02% | 70.38% | 66.32% | 70.35% | 65.59% | 62.94% | 60.73% | 67.58% | 60.13% | 67.31% | 58.96% | 64.62% | 61.87% | 59.45% | 59.04% | 60.92% | 65.54% |
operating expenses: | |||||||||||||||||||||||||||
sales and marketing | 16,537,000 | 14,490,000 | 15,227,000 | 16,857,000 | 16,608,000 | 13,957,000 | 16,472,000 | 16,699,000 | 17,520,000 | 17,164,000 | 14,474,000 | 14,577,000 | 13,466,000 | 11,647,000 | 11,172,000 | 11,055,000 | 9,378,000 | 8,313,000 | 6,948,000 | 7,502,000 | 6,299,000 | 6,377,000 | 6,342,000 | 4,123,000 | 5,269,000 | 5,382,000 | 4,736,000 |
general and administrative | 4,166,000 | 3,784,000 | 3,948,000 | 4,126,000 | 3,836,000 | 3,589,000 | 3,683,000 | 3,621,000 | 3,829,000 | 4,053,000 | 3,728,000 | 3,472,000 | 3,634,000 | 3,242,000 | 3,532,000 | 3,630,000 | 3,458,000 | 3,275,000 | 3,462,000 | 2,966,000 | 2,756,000 | 2,869,000 | 2,607,000 | 2,149,000 | 2,518,000 | 2,486,000 | 1,208,000 |
research and development | 2,343,000 | 2,129,000 | 2,348,000 | 2,203,000 | 2,540,000 | 2,029,000 | 2,068,000 | 2,323,000 | 2,393,000 | 2,685,000 | 2,368,000 | 2,514,000 | 2,052,000 | 2,726,000 | 2,102,000 | 2,102,000 | 2,007,000 | 1,725,000 | 1,409,000 | 1,930,000 | 1,679,000 | 1,163,000 | 1,201,000 | 979,000 | 912,000 | 921,000 | 516,000 |
total operating expenses | 23,046,000 | 20,403,000 | 21,523,000 | 23,186,000 | 22,984,000 | 19,575,000 | 22,223,000 | 22,643,000 | 23,742,000 | 23,902,000 | 20,570,000 | 20,563,000 | 19,152,000 | 17,615,000 | 16,806,000 | 16,787,000 | 14,843,000 | 13,313,000 | 11,819,000 | 12,398,000 | 10,734,000 | 10,409,000 | 10,150,000 | 7,251,000 | 8,699,000 | 8,789,000 | 6,460,000 |
income from operations | -10,526,000 | -6,648,000 | -7,554,000 | -9,081,000 | -10,472,000 | -8,354,000 | -9,365,000 | -11,570,000 | -4,826,000 | -12,278,000 | -10,181,000 | -10,362,000 | -11,254,000 | -9,439,000 | -9,487,000 | -10,237,000 | -9,844,000 | -7,654,000 | -7,217,000 | -7,311,000 | -7,269,000 | -6,747,000 | -6,863,000 | -5,166,000 | -6,499,000 | -5,826,000 | -3,856,000 |
yoy | 0.52% | -20.42% | -19.34% | -21.51% | 116.99% | -31.96% | -8.01% | 11.66% | -57.12% | 30.08% | 7.32% | 1.22% | 14.32% | 23.32% | 31.45% | 40.02% | 35.42% | 13.44% | 5.16% | 41.52% | 11.85% | 15.81% | 77.98% | ||||
qoq | 58.33% | -11.99% | -16.82% | -13.28% | 25.35% | -10.80% | -19.06% | 139.74% | -60.69% | 20.60% | -1.75% | -7.93% | 19.23% | -0.51% | -7.33% | 3.99% | 28.61% | 6.06% | -1.29% | 0.58% | 7.74% | -1.69% | 32.85% | -20.51% | 11.55% | 51.09% | |
operating margin % | -55.23% | -31.86% | -36.51% | -44.96% | -56.54% | -47.33% | -49.40% | -71.90% | -29.07% | -72.23% | -67.64% | -71.49% | -94.50% | -81.22% | -85.02% | -98.38% | -119.60% | -91.40% | -94.29% | -96.73% | -123.69% | -119.06% | -129.17% | -147.31% | -174.42% | -119.78% | -97.06% |
other income: | |||||||||||||||||||||||||||
interest expense | -2,053,000 | -1,637,000 | -1,201,000 | -1,188,000 | -1,219,000 | -1,283,000 | -1,344,000 | -1,331,000 | -1,332,000 | -1,345,000 | -1,334,000 | -1,298,000 | -1,246,000 | -1,174,000 | -1,032,000 | -934,000 | -911,000 | -922,000 | -922,000 | -864,000 | -889,000 | -903,000 | -898,000 | -884,000 | -879,000 | -884,000 | -899,000 |
other income | 366,000 | 277,000 | 152,000 | 379,000 | 479,000 | 285,000 | 337,000 | 301,000 | 497,000 | 733,000 | 558,000 | 870,000 | 473,000 | -107,000 | -43,000 | -127,000 | -80,000 | 22,000 | -140,000 | 58,000 | -31,000 | 158,000 | 179,000 | 55,000 | |||
total other expense | -1,687,000 | -2,248,000 | -1,049,000 | -809,000 | -740,000 | -998,000 | -1,007,000 | -1,030,000 | -835,000 | -612,000 | -776,000 | -428,000 | -773,000 | -540,000 | -1,227,000 | -2,504,000 | -1,018,000 | -965,000 | -1,049,000 | -944,000 | -867,000 | ||||||
loss before income tax expense | -12,213,000 | -7,426,250 | -8,603,000 | -9,890,000 | -11,212,000 | ||||||||||||||||||||||
income tax expense | -60,000 | -21,250 | -33,000 | -52,000 | |||||||||||||||||||||||
net income | -12,273,000 | -9,041,000 | -8,603,000 | -9,923,000 | -11,264,000 | -9,208,000 | -10,372,000 | -12,600,000 | -5,661,000 | -12,890,000 | -10,957,000 | -10,790,000 | -12,027,000 | -9,979,000 | -10,714,000 | -12,741,000 | -10,862,000 | -8,619,000 | -8,266,000 | -8,255,000 | -8,136,000 | -7,790,000 | -7,703,000 | -6,081,000 | -7,220,000 | -6,532,000 | -4,666,000 |
yoy | 8.96% | -1.81% | -17.06% | -21.25% | 98.98% | -28.56% | -5.34% | 16.77% | -52.93% | 29.17% | 2.27% | -15.31% | 10.73% | 15.78% | 29.62% | 54.34% | 33.51% | 10.64% | 7.31% | 35.75% | 12.69% | 19.26% | 65.09% | ||||
qoq | 35.75% | 5.09% | -13.30% | -11.91% | 22.33% | -11.22% | -17.68% | 122.58% | -56.08% | 17.64% | 1.55% | -10.29% | 20.52% | -6.86% | -15.91% | 17.30% | 26.02% | 4.27% | 0.13% | 1.46% | 4.44% | 1.13% | 26.67% | -15.78% | 10.53% | 39.99% | |
net income margin % | -64.39% | -43.32% | -41.58% | -49.13% | -60.82% | -52.17% | -54.71% | -78.30% | -34.10% | -75.83% | -72.79% | -74.44% | -100.99% | -85.86% | -96.01% | -122.44% | -131.96% | -102.93% | -108.00% | -109.22% | -138.44% | -137.46% | -144.98% | -173.40% | -193.77% | -134.29% | -117.44% |
net loss per common share, basic and diluted | -210 | -170 | -190 | -220 | -250 | -170 | -420 | -510 | -230 | -530 | -450 | -460 | -630 | -480 | -640 | -880 | -750 | -590 | -570 | -570 | -560 | -540 | -530 | -530 | -630 | 59,520 | -22,580 |
weighted-average common shares outstanding, basic and diluted | 57,256,518,000 | 46,947,932,000 | 45,421,795,000 | 45,365,325,000 | 45,267,020,000 | 28,526,441,000 | 24,703,578,000 | 24,663,234,000 | 24,579,386,000 | 22,868,663,000 | 24,483,664,000 | 23,239,262,000 | 19,185,621,000 | 16,267,678,000 | 16,758,573,000 | 14,557,453,000 | 14,538,864,000 | 14,473,213,000 | 14,485,688,000 | 14,458,911,000 | 14,438,405,000 | 12,934,421,000 | 14,421,990,000 | 11,443,122,000 | 11,406,783,000 | 1,766,412,000 | 297,750,000 |
comprehensive loss: | |||||||||||||||||||||||||||
foreign currency translation adjustment | -6,000 | -2,000 | 2,000 | 1,000 | -59,000 | 51,000 | 1,000 | 6,000 | -44,000 | 51,000 | -36,000 | -30,000 | -112,000 | 133,000 | 134,000 | 47,000 | -9,000 | 38,000 | 1,000 | -11,000 | -54,000 | -29,000 | 4,000 | 27,000 | 1,000 | ||
comprehensive loss | -12,279,000 | -9,041,000 | -8,605,000 | -9,921,000 | -11,263,000 | -9,267,000 | -10,321,000 | -12,599,000 | -5,655,000 | -12,934,000 | -10,906,000 | -10,826,000 | -12,057,000 | -10,091,000 | -10,581,000 | -12,607,000 | -10,815,000 | -8,628,000 | -8,228,000 | -8,254,000 | -8,147,000 | -7,844,000 | -7,732,000 | -6,077,000 | -7,193,000 | -6,549,000 | -4,665,000 |
other operating income: | |||||||||||||||||||||||||||
gain on sale of product line | -7,580,000 | ||||||||||||||||||||||||||
other expense: | |||||||||||||||||||||||||||
loss on extinguishment of debt | -1,228,000 | ||||||||||||||||||||||||||
other expense | -161,000 | -195,000 | -342,000 | ||||||||||||||||||||||||
change in fair value of preferred stock warrant liability | 34,000 | ||||||||||||||||||||||||||
total other income | -619,000 | -840,000 | -915,000 | -721,000 | -706,000 | -810,000 | |||||||||||||||||||||
accretion of redeemable convertible preferred stock to redemption value | -940,000 | -2,058,000 | |||||||||||||||||||||||||
net loss attributable to common stockholders | -7,790,000 | -7,703,000 | -6,081,000 | -7,220,000 | -7,472,000 | -6,724,000 | |||||||||||||||||||||
gain on litigation settlement |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||
cash and cash equivalents | 50,845,000 | 29,713,000 | 34,977,000 | 42,833,000 | 52,670,000 | 17,301,000 | 26,496,000 | 37,143,000 | 46,729,000 | 58,202,000 | 65,266,000 | 30,124,000 | 42,019,000 | 54,226,000 | 27,725,000 | 33,016,000 | 43,931,000 | 53,636,000 | 60,292,000 | 65,829,000 | 74,394,000 | 81,467,000 | 85,471,000 | 41,411,000 | 45,302,000 | 10,701,000 |
accounts receivable | 10,347,000 | 11,274,000 | 11,236,000 | 10,557,000 | 10,098,000 | 11,222,000 | 9,097,000 | 9,955,000 | 9,737,000 | 8,072,000 | 7,894,000 | 6,654,000 | 6,621,000 | 5,688,000 | 5,306,000 | 4,311,000 | 4,234,000 | 3,573,000 | 3,545,000 | 2,795,000 | 2,683,000 | 2,640,000 | 2,586,000 | 2,047,000 | 2,836,000 | 2,278,000 |
inventory | 11,016,000 | 11,558,000 | 11,371,000 | 13,533,000 | 12,781,000 | 13,600,000 | 13,372,000 | 13,602,000 | 13,162,000 | 14,323,000 | 14,098,000 | 15,105,000 | 11,792,000 | 12,138,000 | 10,291,000 | 10,267,000 | 7,658,000 | 6,269,000 | 4,503,000 | 4,688,000 | 3,907,000 | 4,042,000 | 4,572,000 | 4,803,000 | 4,603,000 | 4,272,000 |
prepaid expenses and other current assets | 3,373,000 | 3,503,000 | 3,161,000 | 2,822,000 | 2,522,000 | 2,009,000 | ||||||||||||||||||||
total current assets | 75,581,000 | 56,048,000 | 60,745,000 | 69,745,000 | 78,071,000 | 44,132,000 | 51,109,000 | 62,618,000 | 71,726,000 | 82,252,000 | 89,168,000 | 53,502,000 | 62,447,000 | 73,955,000 | 45,634,000 | 50,329,000 | 59,055,000 | 65,539,000 | 70,735,000 | 75,204,000 | 83,225,000 | 89,016,000 | 94,113,000 | 55,313,000 | 64,334,000 | 17,616,000 |
property and equipment | 2,226,000 | 2,213,000 | 2,167,000 | 2,201,000 | 2,341,000 | 2,423,000 | 2,349,000 | 2,325,000 | 1,984,000 | 1,749,000 | 1,764,000 | 1,695,000 | 1,682,000 | 1,748,000 | 1,706,000 | 1,460,000 | 1,186,000 | 891,000 | 609,000 | 584,000 | 626,000 | 652,000 | 678,000 | 693,000 | 677,000 | 716,000 |
intangible assets | 1,359,000 | 1,454,000 | 1,549,000 | 1,644,000 | 1,739,000 | 1,834,000 | 1,929,000 | 2,024,000 | 2,119,000 | 2,214,000 | 2,309,000 | 2,404,000 | 2,499,000 | 2,594,000 | 2,689,000 | 2,227,000 | 2,303,000 | 2,379,000 | 2,455,000 | 2,531,000 | 2,607,000 | 2,683,000 | 2,759,000 | 2,835,000 | 2,911,000 | 2,987,000 |
right-of-use assets | 1,502,000 | 1,560,000 | 1,616,000 | 1,678,000 | 1,738,000 | 1,796,000 | 1,851,000 | 1,904,000 | 1,954,000 | 1,102,000 | 1,145,000 | 1,187,000 | 1,227,000 | 1,266,000 | 1,304,000 | |||||||||||
other long-term assets | 500,000 | 1,131,000 | 1,626,000 | 2,276,000 | 2,566,000 | 2,701,000 | 2,701,000 | |||||||||||||||||||
deferred tax asset | 62,000 | 64,000 | 92,000 | 140,000 | ||||||||||||||||||||||
restricted cash | 250,000 | 250,000 | 265,000 | 265,000 | 265,000 | 265,000 | 265,000 | 265,000 | 265,000 | |||||||||||||||||
total assets | 81,418,000 | 61,587,000 | 67,537,000 | 77,251,000 | 86,570,000 | 53,016,000 | 60,204,000 | 71,837,000 | 78,048,000 | 87,317,000 | 94,386,000 | 58,788,000 | 67,855,000 | 79,563,000 | 51,333,000 | 55,355,000 | 62,544,000 | 68,809,000 | 73,799,000 | 78,319,000 | 86,458,000 | 92,351,000 | 97,550,000 | 58,841,000 | 67,922,000 | 23,050,000 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||
accounts payable | 2,309,000 | 2,373,000 | 1,741,000 | 4,002,000 | 2,147,000 | 2,479,000 | 2,314,000 | 3,357,000 | 1,667,000 | 3,091,000 | 2,250,000 | 5,216,000 | 1,534,000 | 4,856,000 | 2,246,000 | 5,703,000 | 2,414,000 | 2,334,000 | 1,277,000 | 965,000 | 652,000 | 976,000 | 948,000 | 1,389,000 | 3,171,000 | 1,701,000 |
accrued expenses and other current liabilities | 15,666,000 | 14,604,000 | 13,987,000 | 12,534,000 | 13,451,000 | 14,379,000 | 12,675,000 | 11,822,000 | 15,300,000 | 12,243,000 | 10,795,000 | 9,190,000 | 10,869,000 | 10,358,000 | 9,680,000 | 6,583,000 | 8,161,000 | 7,043,000 | 6,017,000 | 4,673,000 | 5,953,000 | 4,369,000 | 2,675,000 | |||
total current liabilities | 17,975,000 | 16,977,000 | 19,061,000 | 16,536,000 | 15,598,000 | 16,858,000 | 14,989,000 | 15,179,000 | 16,967,000 | 15,334,000 | 13,045,000 | 14,406,000 | 12,403,000 | 15,214,000 | 11,926,000 | 12,286,000 | 10,575,000 | 9,377,000 | 7,294,000 | 5,638,000 | 6,605,000 | 5,345,000 | 3,623,000 | 4,232,000 | 6,713,000 | 6,309,000 |
long‑term debt | 55,653,000 | 41,494,000 | 38,051,000 | 41,275,000 | 41,124,000 | 40,970,000 | 40,817,000 | 40,665,000 | 40,515,000 | 40,363,000 | 40,212,000 | 40,063,000 | 39,916,000 | 39,766,000 | 39,617,000 | |||||||||||
other long‑term liabilities | 1,477,000 | 1,559,000 | 1,241,000 | 1,317,000 | 1,390,000 | 1,460,000 | 1,528,000 | 1,609,000 | 1,685,000 | 1,068,000 | 1,124,000 | 1,178,000 | 1,231,000 | 1,282,000 | 1,332,000 | 1,362,000 | 380,000 | 388,000 | 395,000 | 8,000 | 1,000 | 4,000 | 5,000 | |||
total liabilities | 75,105,000 | 60,030,000 | 58,353,000 | 59,128,000 | 58,112,000 | 59,288,000 | 57,334,000 | 57,453,000 | 59,167,000 | 56,765,000 | 54,381,000 | 55,647,000 | 53,550,000 | 56,262,000 | 52,875,000 | 45,317,000 | 42,446,000 | 41,080,000 | 38,834,000 | 36,628,000 | 37,432,000 | 36,018,000 | 34,147,000 | 34,614,000 | 36,960,000 | 38,066,000 |
commitments and contingencies | ||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||
preferred stock; 0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||||||||
common stock; 0.001 | 44,000 | 40,000 | 40,000 | 40,000 | 39,000 | 25,000 | 25,000 | 25,000 | 24,000 | 24,000 | 24,000 | 19,000 | 19,000 | 19,000 | 15,000 | 15,000 | 15,000 | 15,000 | 14,000 | 14,000 | 14,000 | 14,000 | 14,000 | 11,000 | 11,000 | |
additional paid-in capital | 403,739,000 | 389,946,000 | 388,968,000 | 387,986,000 | 387,059,000 | 343,076,000 | 341,897,000 | 340,812,000 | 339,655,000 | 338,392,000 | 336,939,000 | 289,254,000 | 288,361,000 | 287,266,000 | 251,846,000 | 250,819,000 | 250,064,000 | 249,067,000 | 248,076,000 | 246,548,000 | 245,736,000 | 245,199,000 | 244,537,000 | 199,287,000 | 198,829,000 | |
accumulated other comprehensive income | 91,000 | 91,000 | 93,000 | 91,000 | 90,000 | 149,000 | 98,000 | 97,000 | 91,000 | 135,000 | 84,000 | 120,000 | 150,000 | 262,000 | 129,000 | 12,000 | 8,000 | |||||||||
accumulated deficit | -397,561,000 | -388,520,000 | -379,917,000 | -369,994,000 | -358,730,000 | -349,522,000 | -339,150,000 | -326,550,000 | -320,889,000 | -307,999,000 | -297,042,000 | -286,252,000 | -274,225,000 | -264,246,000 | -253,532,000 | -240,791,000 | -229,929,000 | -221,310,000 | -213,044,000 | -204,789,000 | -196,653,000 | -188,863,000 | -181,160,000 | -175,079,000 | -167,859,000 | -160,398,000 |
total stockholders’ equity | 6,313,000 | 1,557,000 | 9,184,000 | 18,123,000 | 28,458,000 | 2,870,000 | 14,384,000 | 18,881,000 | 30,552,000 | 40,005,000 | 3,141,000 | 14,305,000 | 23,301,000 | 10,038,000 | 20,098,000 | 27,729,000 | 34,965,000 | 41,691,000 | 49,026,000 | 56,333,000 | 63,403,000 | 24,227,000 | 30,962,000 | |||
total liabilities and stockholders’ equity | 81,418,000 | 61,587,000 | 67,537,000 | 77,251,000 | 86,570,000 | 60,204,000 | 71,837,000 | 78,048,000 | 87,317,000 | 94,386,000 | 58,788,000 | 67,855,000 | 79,563,000 | 55,355,000 | 62,544,000 | 68,809,000 | 73,799,000 | 78,319,000 | 86,458,000 | 92,351,000 | 97,550,000 | 58,841,000 | ||||
current portion of long-term debt | 3,333,000 | |||||||||||||||||||||||||
| ||||||||||||||||||||||||||
liabilities and stockholders’ (deficit) equity | ||||||||||||||||||||||||||
stockholders’ (deficit) equity: | ||||||||||||||||||||||||||
total stockholders’ (deficit) equity | -6,272,000 | -1,542,000 | ||||||||||||||||||||||||
total liabilities and stockholders’ (deficit) equity | 53,016,000 | 51,333,000 | ||||||||||||||||||||||||
prepaid expenses and other assets | 2,144,000 | 1,918,000 | 2,098,000 | 1,655,000 | 1,910,000 | 1,619,000 | 2,015,000 | 1,903,000 | 2,312,000 | 2,735,000 | 3,232,000 | 2,061,000 | 2,395,000 | 1,892,000 | 2,241,000 | 867,000 | 1,484,000 | 1,763,000 | 2,308,000 | 365,000 | ||||||
long‑term debt with related party | 31,669,000 | 31,491,000 | 31,315,000 | 31,145,000 | 30,982,000 | 30,827,000 | 30,673,000 | 30,524,000 | 30,381,000 | 30,243,000 | 30,108,000 | |||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||
right-of-use asset | 1,339,000 | |||||||||||||||||||||||||
accumulated other comprehensive loss | -5,000 | -52,000 | -43,000 | -81,000 | -82,000 | -71,000 | -17,000 | -19,000 | ||||||||||||||||||
short-term investments | 5,289,000 | 9,285,000 | ||||||||||||||||||||||||
contingencies and commitments | ||||||||||||||||||||||||||
accrued expenses | 2,834,000 | 3,533,000 | 3,600,000 | |||||||||||||||||||||||
other current liabilities | 9,000 | 9,000 | 1,008,000 | |||||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||||||
preferred stock warrant liability | 1,644,000 | |||||||||||||||||||||||||
redeemable convertible preferred stock | ||||||||||||||||||||||||||
series a preferred stock: 22,501,174 shares previously authorized, no shares issued or outstanding at december 31, 2019 and 22,501,174 issued and outstanding at december 31, 2018 | ||||||||||||||||||||||||||
series b preferred stock: 82,891,619 shares previously authorized, no shares issued or outstanding at december 31, 2019 and 63,032,500 issued and outstanding at december 31, 2018 | ||||||||||||||||||||||||||
total redeemable convertible preferred stock | 145,384,000 | |||||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ equity | 67,922,000 | |||||||||||||||||||||||||
deferred offering costs | 1,731,000 | |||||||||||||||||||||||||
liabilities, redeemable convertible preferred stock, and stockholders’ deficit | ||||||||||||||||||||||||||
series a preferred stock: 22,501,174 shares authorized, issued, and outstanding at september 30, 2019 and december 31, 2018; liquidation value of 34,458 at september 30, 2019 | 34,458,000 | |||||||||||||||||||||||||
series b preferred stock: 82,891,619 shares authorized,75,560,456 and 63,032,500 issued and outstanding at september 30, 2019 and december 31, 2018, respectively; liquidation value of 110,213 at september 30, 2019 | 110,926,000 | |||||||||||||||||||||||||
stockholders’ deficit: | ||||||||||||||||||||||||||
total stockholders’ deficit | -160,400,000 | |||||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ deficit | 23,050,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||
net loss | -12,273,000 | -9,041,000 | -8,603,000 | -9,923,000 | -11,264,000 | -9,208,000 | -10,372,000 | -12,600,000 | -5,661,000 | -12,890,000 | -10,957,000 | -10,790,000 | -12,027,000 | -10,714,000 | -12,741,000 | -10,862,000 | -8,266,000 | -8,255,000 | -8,136,000 | -7,790,000 | -7,703,000 | -6,081,000 | -7,220,000 | -6,532,000 | ||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||||||||
depreciation expense | 169,000 | 130,000 | 153,000 | 175,000 | 172,000 | 171,000 | 168,000 | 154,000 | 139,000 | 66,000 | 123,000 | 119,000 | 120,000 | 112,000 | 110,000 | 83,000 | 78,000 | 61,000 | 51,000 | 55,000 | 64,000 | 63,000 | 63,000 | 39,000 | 56,000 | 72,000 |
noncash interest expense | 238,000 | 159,000 | 110,000 | 109,000 | 151,000 | 154,000 | 153,000 | 151,000 | 151,000 | 152,000 | 151,000 | 149,000 | 147,000 | 150,000 | 148,000 | 181,000 | 178,000 | 176,000 | 170,000 | 162,000 | 156,000 | 154,000 | 149,000 | 147,000 | 134,000 | 128,000 |
amortization of intangible assets | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 95,000 | 538,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 | 76,000 |
net changes in operating lease rou assets and liabilities | -21,000 | -21,000 | 375,000 | -26,000 | -26,000 | -26,000 | -26,000 | -25,000 | -22,000 | -16,000 | -11,000 | -12,000 | -10,000 | -10,000 | -9,000 | -9,000 | -8,000 | |||||||||
inventory excess and obsolescence charge | 935,000 | 818,000 | 632,000 | 280,000 | 630,000 | 1,392,000 | 655,000 | 348,000 | 560,000 | 422,000 | 288,000 | 128,000 | 576,000 | 57,000 | 616,000 | 348,000 | 845,000 | 105,000 | 652,000 | 100,000 | 582,000 | 106,000 | 454,000 | 362,000 | 405,000 | 498,000 |
stock‑based compensation expense | 816,000 | 812,000 | 955,000 | 985,000 | 1,044,000 | 1,089,000 | 1,081,000 | 1,090,000 | 1,102,000 | 1,241,000 | 1,369,000 | 1,294,000 | 1,128,000 | 1,039,000 | 1,027,000 | 1,022,000 | 901,000 | 822,000 | 733,000 | 1,412,000 | 694,000 | 572,000 | 543,000 | 494,000 | 449,000 | 274,000 |
income tax expense | 60,000 | |||||||||||||||||||||||||
loss on disposal of fixed assets | 18,000 | |||||||||||||||||||||||||
change in operating assets and liabilities: | ||||||||||||||||||||||||||
accounts receivable | 593,000 | 932,000 | -107,000 | -533,000 | -402,000 | 983,000 | -2,008,000 | 497,000 | -234,000 | -1,602,000 | -237,000 | -1,201,000 | -18,000 | -890,000 | -416,000 | -1,030,000 | -85,000 | -657,000 | -34,000 | -750,000 | -112,000 | -41,000 | -48,000 | -543,000 | 781,000 | -545,000 |
inventory | -2,158,000 | -275,000 | -838,000 | 1,956,000 | -1,346,000 | -616,000 | -811,000 | -115,000 | -1,430,000 | 785,000 | -567,000 | 924,000 | -3,860,000 | 467,000 | -2,553,000 | -482,000 | -3,505,000 | -1,493,000 | -2,426,000 | 85,000 | -1,360,000 | 44,000 | 86,000 | -133,000 | -617,000 | -816,000 |
prepaid expenses and other current and long-term assets | 231,000 | |||||||||||||||||||||||||
accounts payable | 1,593,000 | -63,000 | 652,000 | -2,301,000 | 1,853,000 | -154,000 | 42,000 | -921,000 | 1,515,000 | -1,524,000 | 884,000 | -3,011,000 | 3,662,000 | -3,175,000 | 2,702,000 | -3,685,000 | 3,274,000 | 11,000 | 1,016,000 | 258,000 | 312,000 | -327,000 | 421,000 | -835,000 | -1,261,000 | 1,697,000 |
accrued expenses and other current and long-term liabilities | -1,498,000 | 663,000 | 633,000 | 1,394,000 | -930,000 | -842,000 | 1,660,000 | 847,000 | -3,474,000 | 2,804,000 | 1,477,000 | 1,587,000 | -1,691,000 | 1,600,000 | 583,000 | 2,136,000 | -1,920,000 | 1,112,000 | ||||||||
foreign currency transaction loss | 32,000 | 41,000 | -48,000 | 17,000 | 66,000 | |||||||||||||||||||||
net cash from operating activities | -11,170,000 | -4,870,000 | -5,719,000 | -7,905,000 | -9,725,000 | -7,531,000 | -8,983,000 | -10,697,000 | -14,384,000 | -11,051,000 | -6,968,000 | -11,264,000 | -11,574,000 | -10,983,000 | -7,649,000 | -11,686,000 | -10,430,000 | -9,588,000 | -6,630,000 | -5,629,000 | -8,585,000 | -7,104,000 | -3,690,000 | -6,355,000 | -7,307,000 | -7,184,000 |
capital expenditures | -119,000 | -91,000 | -211,000 | -114,000 | -32,000 | -264,000 | -122,000 | -299,000 | -304,000 | -205,000 | -134,000 | -157,000 | -115,000 | -46,000 | -290,000 | -200,000 | -336,000 | -289,000 | -291,000 | -25,000 | -22,000 | -38,000 | -33,000 | -28,000 | -68,000 | 0 |
free cash flows | -11,289,000 | -4,961,000 | -5,930,000 | -8,019,000 | -9,757,000 | -7,795,000 | -9,105,000 | -10,996,000 | -14,688,000 | -11,256,000 | -7,102,000 | -11,421,000 | -11,689,000 | -11,029,000 | -7,939,000 | -11,886,000 | -10,766,000 | -9,877,000 | -6,921,000 | -5,654,000 | -8,607,000 | -7,142,000 | -3,723,000 | -6,383,000 | -7,375,000 | -7,184,000 |
cash flows from investing activities: | ||||||||||||||||||||||||||
purchase of property and equipment | -119,000 | -91,000 | -211,000 | -114,000 | -32,000 | -264,000 | -122,000 | -299,000 | -304,000 | -205,000 | -134,000 | -157,000 | -115,000 | -46,000 | -290,000 | -200,000 | -336,000 | -289,000 | -291,000 | -25,000 | -22,000 | -38,000 | -33,000 | -28,000 | -68,000 | |
proceeds from the sale of product line | 309,000 | 283,000 | 523,000 | 318,000 | 170,000 | 74,000 | 0 | 366,000 | 5,000,000 | |||||||||||||||||
net cash from investing activities | 190,000 | 192,000 | 312,000 | 204,000 | 138,000 | -190,000 | -122,000 | 67,000 | 4,696,000 | -193,000 | -134,000 | -157,000 | -115,000 | -1,046,000 | -290,000 | -200,000 | -336,000 | -289,000 | -291,000 | -25,000 | -22,000 | -38,000 | -33,000 | 5,261,000 | 3,932,000 | -9,317,000 |
cash flows from financing activities: | ||||||||||||||||||||||||||
payment of accrued offering costs | -247,000 | |||||||||||||||||||||||||
vesting of restricted stock units | 1,000 | |||||||||||||||||||||||||
payment of withholding taxes related to stock-based compensation to employees | -79,000 | -4,000 | -21,000 | -3,000 | -177,000 | -11,000 | -19,000 | -11,000 | -328,000 | -4,000 | -5,000 | -1,000 | -279,000 | 0 | -4,000 | 0 | -153,000 | |||||||||
proceeds from issuance of common stock under the employee stock purchase plan | 27,000 | 0 | 45,000 | 0 | 60,000 | 0 | 117,000 | 0 | 164,000 | 0 | ||||||||||||||||
net cash from financing activities | -298,000 | 25,845,000 | 24,000 | -3,000 | -116,000 | 42,908,000 | 98,000 | -5,000 | 56,000 | 22,000 | 71,000 | 46,409,000 | -235,000 | -219,000 | 34,569,000 | 6,648,000 | -146,000 | 174,000 | 259,000 | 116,000 | 36,000 | 46,000 | -279,000 | 45,156,000 | -514,000 | 51,105,000 |
effect of exchange rate on cash and cash equivalents | -26,000 | -35,000 | 104,000 | -152,000 | -134,000 | 182,000 | -188,000 | -12,000 | 46,000 | 14,000 | -33,000 | 154,000 | 29,000 | 41,000 | -129,000 | -53,000 | -3,000 | -2,000 | 6,000 | 1,000 | 6,000 | |||||
net decrease in cash and cash equivalents and restricted cash | -11,304,000 | -5,279,000 | -7,856,000 | -9,837,000 | -9,586,000 | |||||||||||||||||||||
cash and cash equivalents and restricted cash, beginning of period | 51,095,000 | 0 | 0 | 52,935,000 | 0 | 0 | 46,994,000 | |||||||||||||||||||
cash and cash equivalents and restricted cash, end of period | 39,791,000 | -5,279,000 | -7,856,000 | 43,098,000 | -9,195,000 | -10,647,000 | 37,408,000 | |||||||||||||||||||
supplemental disclosure of cash flow information: | ||||||||||||||||||||||||||
cash paid during the period for interest | 1,815,000 | 738,000 | 1,311,000 | 1,297,000 | 1,370,000 | 519,000 | 1,191,000 | 1,180,000 | 1,181,000 | 1,193,000 | 1,183,000 | 1,149,000 | 1,099,000 | 1,024,000 | 884,000 | 753,000 | 733,000 | 746,000 | 752,000 | 702,000 | 733,000 | 749,000 | 749,000 | 737,000 | 745,000 | 756,000 |
noncash loss on extinguishment of debt | 0 | 0 | ||||||||||||||||||||||||
gain on disposal of fixed assets | ||||||||||||||||||||||||||
gain on sale of product line | 0 | 0 | 0 | -7,580,000 | ||||||||||||||||||||||
proceeds from the sale of property and equipment | ||||||||||||||||||||||||||
proceeds from sale of common stock and pre-funded warrants | ||||||||||||||||||||||||||
proceeds from issuance of long-term debt and warrants | ||||||||||||||||||||||||||
repayment of long-term debt | ||||||||||||||||||||||||||
payment of debt financing costs | 0 | |||||||||||||||||||||||||
proceeds from exercise of stock options | 0 | 0 | 0 | 1,000 | 0 | 0 | 6,000 | 220,000 | 26,000 | 1,000 | 56,000 | 44,000 | 6,000 | 1,000 | 5,000 | 7,000 | 136,000 | 259,000 | 116,000 | 36,000 | 12,000 | 119,000 | 36,000 | 8,000 | 2,000 | |
net increase in cash and cash equivalents and restricted cash | 35,369,000 | -9,195,000 | ||||||||||||||||||||||||
cash and cash equivalents and restricted cash, beginning of year | ||||||||||||||||||||||||||
cash and cash equivalents and restricted cash, end of year | ||||||||||||||||||||||||||
supplemental disclosures of noncash investing and financing activities: | ||||||||||||||||||||||||||
property and equipment in accounts payable and accrued expenses and other current liabilities | 51,000 | -11,000 | 120,000 | -121,000 | 176,000 | 96,000 | -26,000 | 31,000 | 18,000 | -1,000 | ||||||||||||||||
operating lease rou asset exchanged for operating lease liabilities | 0 | 0 | 2,000 | 1,374,000 | ||||||||||||||||||||||
offering costs in accrued expenses and other current liabilities | ||||||||||||||||||||||||||
issuance of common stock warrants in connection with credit facility | ||||||||||||||||||||||||||
deferred income tax expense | 0 | 33,000 | 52,000 | |||||||||||||||||||||||
prepaid expenses and other current assets | 272,000 | -166,000 | 180,000 | -297,000 | 271,000 | -226,000 | 479,000 | -442,000 | 254,000 | -291,000 | 398,000 | |||||||||||||||
deferred income tax benefit | ||||||||||||||||||||||||||
payment for intangible asset | 0 | |||||||||||||||||||||||||
proceeds from issuance of long-term debt | ||||||||||||||||||||||||||
tenant improvement and deferred rent reclassified to operating lease liabilities | 0 | 0 | 0 | 380,000 | ||||||||||||||||||||||
operating lease liabilities assumed for operating lease rou assets | 0 | 0 | 3,510,000 | -1,754,000 | ||||||||||||||||||||||
foreign currency transaction gain | ||||||||||||||||||||||||||
proceeds from sale of common stock | ||||||||||||||||||||||||||
foreign currency translation loss | 8,000 | -24,000 | ||||||||||||||||||||||||
proceeds from sale of common stock, net of underwriting discounts, commissions and offering costs | 0 | -13,000 | -275,000 | |||||||||||||||||||||||
offering costs in accounts payable and accrued expenses and other current liabilities | ||||||||||||||||||||||||||
proceeds from the sale property and equipment | ||||||||||||||||||||||||||
proceeds from issuance of long‑term debt | 0 | 0 | ||||||||||||||||||||||||
repayment of long‑term debt | 0 | 0 | ||||||||||||||||||||||||
issuance of common stock for early exercised stock options | 1,000 | 0 | 1,000 | 1,000 | 1,000 | |||||||||||||||||||||
reclassification of liability-classified stock-based compensation awards to equity-classified | 0 | 0 | ||||||||||||||||||||||||
foreign currency remeasurement loss | 163,000 | -255,000 | -94,000 | -343,000 | 360,000 | 302,000 | 101,000 | -12,000 | 41,000 | 0 | -17,000 | -38,000 | 7,000 | 38,000 | ||||||||||||
net increase in cash and cash equivalents | -7,064,000 | -12,207,000 | -9,705,000 | -6,656,000 | -7,073,000 | -4,004,000 | ||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 42,019,000 | 0 | 0 | 43,931,000 | 0 | 0 | 74,394,000 | 0 | 0 | 45,302,000 | ||||||||||||||
cash and cash equivalents, end of period | -7,064,000 | 35,142,000 | 30,124,000 | 26,501,000 | -5,291,000 | 33,016,000 | -6,656,000 | -5,537,000 | 65,829,000 | -4,004,000 | 44,060,000 | 41,411,000 | ||||||||||||||
intangible asset in accrued expenses and other liabilities | 0 | |||||||||||||||||||||||||
net decrease in cash and cash equivalents | -11,895,000 | -5,291,000 | -10,915,000 | -8,565,000 | -3,891,000 | |||||||||||||||||||||
net income | ||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||
proceeds from the sale and maturity of short-term investments | 0 | 0 | 5,289,000 | 4,000,000 | ||||||||||||||||||||||
payment of initial public offering costs | 0 | 0 | 0 | -522,000 | ||||||||||||||||||||||
cash and cash equivalents, beginning of year | ||||||||||||||||||||||||||
cash and cash equivalents, end of year | ||||||||||||||||||||||||||
liability-classified stock-based compensation in accrued expenses and other current liabilities | ||||||||||||||||||||||||||
prepaid expenses and other assets | 402,000 | 423,000 | 497,000 | -1,172,000 | 334,000 | -503,000 | 349,000 | -1,374,000 | 617,000 | 279,000 | 544,000 | -1,942,000 | ||||||||||||||
payment of financing costs | ||||||||||||||||||||||||||
property and equipment in accounts payable | 130,000 | 16,000 | 69,000 | 42,000 | -1,000 | |||||||||||||||||||||
deferred financing costs in accounts payable and accrued expenses and other liabilities | ||||||||||||||||||||||||||
change in fair value of warrants | 1,000 | |||||||||||||||||||||||||
purchases of short-term investments | ||||||||||||||||||||||||||
proceeds from follow-on offering, net of underwriting discounts, commissions and offering costs | ||||||||||||||||||||||||||
proceeds from initial public offering, net of underwriting discounts, commissions and offering costs | ||||||||||||||||||||||||||
proceeds from issuance of series b redeemable convertible preferred stock, net of offering costs | ||||||||||||||||||||||||||
accretion of redeemable convertible preferred stock | ||||||||||||||||||||||||||
conversion of convertible preferred stock to common stock in connection with the initial public offering | ||||||||||||||||||||||||||
conversion of outstanding preferred stock warrants | ||||||||||||||||||||||||||
unrealized loss on short-term investments | ||||||||||||||||||||||||||
accrued expenses and other current liabilities | 1,731,000 | -1,193,000 | ||||||||||||||||||||||||
reclassification of liability-classified stock-based compensation to equity-classified | 82,000 | |||||||||||||||||||||||||
gain on sale of equipment | ||||||||||||||||||||||||||
restricted cash | ||||||||||||||||||||||||||
foreign currency remeasurement gain | ||||||||||||||||||||||||||
proceeds from issuance of long‑term debt with related party | ||||||||||||||||||||||||||
proceeds from issuance of long‑term debt and preferred stock warrants | ||||||||||||||||||||||||||
borrowings under revolving credit facility | ||||||||||||||||||||||||||
repayments of revolving credit facility | ||||||||||||||||||||||||||
payment of deferred financing costs | ||||||||||||||||||||||||||
effect of exchange rate on cash | ||||||||||||||||||||||||||
cash paid on loss on extinguishment of debt | ||||||||||||||||||||||||||
fair value of warrants issued in connection with equity and debt financing | ||||||||||||||||||||||||||
intangible assets in accrued expenses and other current liabilities | ||||||||||||||||||||||||||
recognition of exit fee for debt discount | ||||||||||||||||||||||||||
accrued expenses and other liabilities | 1,690,000 | -167,000 | -692,000 | -74,000 | ||||||||||||||||||||||
proceeds from underwritten public offering, net of underwriting discounts, commissions and offering costs | -398,000 | |||||||||||||||||||||||||
offering costs in accounts payable and accrued expense and other current liabilities | ||||||||||||||||||||||||||
deferred series b equity costs in accounts payable and accrued expenses | ||||||||||||||||||||||||||
intangible assets in accrued expenses and other liabilities | ||||||||||||||||||||||||||
property and equipment purchases in accounts payable | 4,000 | |||||||||||||||||||||||||
beneficial conversion feature upon conversion of promissory notes | ||||||||||||||||||||||||||
loss on sale of property and equipment | ||||||||||||||||||||||||||
proceeds from sale of property and equipment | ||||||||||||||||||||||||||
proceeds from initial public offering net of underwriting discounts, commissions and offering costs | ||||||||||||||||||||||||||
proceeds from issuance of convertible promissory notes and preferred stock warrants | ||||||||||||||||||||||||||
payment of capital lease obligations | ||||||||||||||||||||||||||
offering costs in accounts payable | ||||||||||||||||||||||||||
conversion of convertible promissory notes and accrued interest to series b redeemable convertible preferred stock | ||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||
purchases of property and equipment | ||||||||||||||||||||||||||
proceeds from issuance of series b redeemable preferred stock | ||||||||||||||||||||||||||
accretion of redeemable preferred stock to redemption value | ||||||||||||||||||||||||||
deferred offering costs in accounts payable and accrued expenses |